The Epidemiologic, Microbiologic and Clinical Picture of Bacteremia among Febrile Infants and Young Children Managed as Outpatients at the Emergency Room, before and after Initiation of the Routine Anti-Pneumococcal Immunization
- PMID: 27447651
- PMCID: PMC4962264
- DOI: 10.3390/ijerph13070723
The Epidemiologic, Microbiologic and Clinical Picture of Bacteremia among Febrile Infants and Young Children Managed as Outpatients at the Emergency Room, before and after Initiation of the Routine Anti-Pneumococcal Immunization
Abstract
We described the occult bacteremia (OB) and bacteremia with diagnosed focus (BwF) picture among children managed as outpatients at the pediatric emergency room (PER) in southern Israel, before and after the introduction of pneumococcal conjugate vaccines (PCVs) introduction in a retrospective study enrolling all three- to 36-month-old patients with fever >38.0 °C during 2005-2014. Of 511 (0.82% of all febrile patients) true bacteremias, 230 (45%) were managed as outpatients; 96 of 230 (41.7%) had OB and 134 (3.59%) had BwF. OB and BwF rates were 0.22% and 3.02%, respectively. A significant decrease was noted in OB and BwF rates (p = 0.0008 and p = 0.02, respectively). S. pneumoniae (SP, 37.5%), K. kingae (11.4%) and Brucella spp. (8.7%) were the most common OB pathogens and SP (29.8%), S. viridans (13.4%), and Brucella spp. (12.7%) were the most common in BwF patients. PCV13 serotypes were not found among the serotypes isolated post-PCV13 introduction. During 2010-2014 there was an increase in non-PCV13 serotype isolation (p = 0.005). SP was the main pathogen isolated among patients with pneumonia, acute otitis media (AOM) and periorbital cellulitis (62.5%, 33.3% and 60%, respectively). OB and BwF decreased following the introduction of PCVs and SP was the main pathogen in both conditions. Vaccine-SP serotypes were not isolated in OB after PCV13 introduction and non-vaccine serotypes increased significantly.
Keywords: Streptococcus pneumoniae; antibiotics; bacteremia with focus; blood cultures; leukocytosis; occult bacteremia.
Figures
Similar articles
-
Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1449-1455. doi: 10.1007/s10096-018-3270-2. Epub 2018 May 7. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29736610
-
Epidemiologic and Microbiologic Characteristics of Occult Bacteremia Among Febrile Children in Southern Israel, Before and After Initiation of the Routine Antipneumococcal Immunization (2005-2012).Pediatr Neonatol. 2016 Oct;57(5):378-384. doi: 10.1016/j.pedneo.2015.10.004. Epub 2015 Dec 8. Pediatr Neonatol. 2016. PMID: 26738763
-
Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.Pediatr Infect Dis J. 2007 Aug;26(8):667-71. doi: 10.1097/INF.0b013e3180f610b3. Pediatr Infect Dis J. 2007. PMID: 17848875
-
Pneumococcal serotype evolution in Western Europe.BMC Infect Dis. 2015 Oct 14;15:419. doi: 10.1186/s12879-015-1147-x. BMC Infect Dis. 2015. PMID: 26468008 Free PMC article. Review.
-
Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization.Pediatr Infect Dis J. 2002 Jun;21(6):584-8; discussion 613-4. doi: 10.1097/00006454-200206000-00033. Pediatr Infect Dis J. 2002. PMID: 12182394 Review.
Cited by
-
Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain.Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1449-1455. doi: 10.1007/s10096-018-3270-2. Epub 2018 May 7. Eur J Clin Microbiol Infect Dis. 2018. PMID: 29736610
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous